Late Breaking

Scientific Programme, ePosters & Abstracts

Previous issue | Volume 98 | ESPE2024

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

The 62nd ESPE Annual Meeting will now be taking place in Liverpool, UK.

Free Communications

Previous section
Fetal and Neonatal Endocrinology

Table of contents

hrp0098fc15.1 | Late Breaking

Response to Daily and Weekly Recombinant Human Growth Hormone Treatment in Children Born Small for Gestational Age is Predicted More Accurately by Pre-treatment Blood Transcriptome than Clinical Variables

hrp0098fc15.2 | Late Breaking

Amount and Pattern Of Pulsatile GH Secretion Induced By The Oral Growth Hormone Secretagogue LUM-201 Is Related To Growth And IGF-1 Responses In Moderate Pediatric Growth Hormone Deficiency (PGHD)

hrp0098fc15.3 | Late Breaking

Assessment of actionable secondary genetic findings in a large cohort of children with short stature

hrp0098fc15.4 | Late Breaking

Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study demonstrate safety and durability of treatment effect on linear growth with improved body proportionality

hrp0098fc15.5 | Late Breaking

Presence of neuropathy in children and adolescents with type 1 diabetes evaluated with bedside modalities

hrp0098fc15.6 | Late Breaking

Pharmacodynamic Endpoints After Once-Weekly Somapacitan in Children With GHD: 3-year results from REAL4 phase 3 study

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Abstracts